Ikeda H - Search Results

1

The efficacy and safety of topical brinzolamide and dorzolamide when added to the combination therapy of latanoprost and a beta-blocker in patients with glaucoma.

Tsukamoto H, Noma H, Matsuyama S, Ikeda H, Mishima HK. Tsukamoto H, et al. Among authors: ikeda h. J Ocul Pharmacol Ther. 2005 Apr;21(2):170-3. doi: 10.1089/jop.2005.21.170. J Ocul Pharmacol Ther. 2005. PMID: 15857284 Clinical Trial.

2

The efficacy and ocular discomfort of substituting brinzolamide for dorzolamide in combination therapy with latanoprost, timolol, and dorzolamide.

Tsukamoto H, Noma H, Mukai S, Ikeda H, Mishima HK. Tsukamoto H, et al. Among authors: ikeda h. J Ocul Pharmacol Ther. 2005 Oct;21(5):395-9. doi: 10.1089/jop.2005.21.395. J Ocul Pharmacol Ther. 2005. PMID: 16245966 Clinical Trial.

3

Clinical significance of topical instillation technique in Japanese glaucoma patients.

Ikeda H, Tsukamoto H, Sugimoto A, Sawa A, Crabtree BL, Byrd HJ, Murakami T, Mishima HK, Kihira K. Ikeda H, et al. Pharmazie. 2008 Jan;63(1):81-5. Pharmazie. 2008. PMID: 18271310

4

Daily cost of ophthalmic solutions used to treat allergic conjunctivitis in Japan.

Ikeda H, Tsukamoto H, Sato E, Mishima HK, Kihira K. Ikeda H, et al. Ophthalmic Epidemiol. 2004 Feb;11(1):35-42. doi: 10.1076/opep.11.1.35.26441. Ophthalmic Epidemiol. 2004. PMID: 14977495

5

[Comparison of annual cost between brand and generic ocular beta-adrenergic blockers].

Ikeda H, Tsukamoto H, Sawa A, Sugimoto A, Mishima H, Kihira K. Ikeda H, et al. Yakugaku Zasshi. 2005 May;125(5):463-7. doi: 10.1248/yakushi.125.463. Yakugaku Zasshi. 2005. PMID: 15863979 Free article. Japanese.

6

The mechanisms by which latanoprost free acid inhibits human carbonic anhydrase I and II.

Sugimoto A, Ikeda H, Tsukamoto H, Kihira K, Takeda C, Hirose J, Hata T, Baba E, Ono Y. Sugimoto A, et al. Among authors: ikeda h. Biol Pharm Bull. 2008 May;31(5):796-801. doi: 10.1248/bpb.31.796. Biol Pharm Bull. 2008. PMID: 18451496 Free article.

7

[Evaluation and multivariate statistical analysis of factors influencing patient adherence to ophthalmic solutions].

Ikeda H, Sato M, Tsukamoto H, Sato E, Unei H, Kimura Y, Mishima H, Kihira K. Ikeda H, et al. Yakugaku Zasshi. 2001 Nov;121(11):799-806. doi: 10.1248/yakushi.121.799. Yakugaku Zasshi. 2001. PMID: 11725548 Free article. Japanese.

8

Timolol activates the enzyme activities of human carbonic anhydrase I and II.

Sugimoto A, Ikeda H, Tsukamoto H, Kihira K, Ishioka M, Hirose J, Hata T, Fujioka H, Ono Y. Sugimoto A, et al. Among authors: ikeda h. Biol Pharm Bull. 2010;33(2):301-6. doi: 10.1248/bpb.33.301. Biol Pharm Bull. 2010. PMID: 20118557 Free article.

9

Daily cost of ophthalmic solutions for treating glaucoma in Japan.

Ikeda H, Sato E, Kitaura T, Fukuchi H, Kimura Y, Kihira K. Ikeda H, et al. Jpn J Ophthalmol. 2001 Jan-Feb;45(1):99-102. doi: 10.1016/s0021-5155(00)00299-9. Jpn J Ophthalmol. 2001. PMID: 11163052

10

Pharmacokinetic interaction on valproic acid and recurrence of epileptic seizures during chemotherapy in an epileptic patient.

Ikeda H, Murakami T, Takano M, Usui T, Kihira K. Ikeda H, et al. Br J Clin Pharmacol. 2005 May;59(5):593-7. doi: 10.1111/j.1365-2125.2005.02339.x. Br J Clin Pharmacol. 2005. PMID: 15842559 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,521 results

Search Page

Filters